Page 25 - Read Online
P. 25

Toscano et al. Neuroimmunol Neuroinflammation 2021;8:14-41  I  http://dx.doi.org/10.20517/2347-8659.2020.12  Page 21

               Table 2. Different cut-off values for kappa index and characteristics of study cohorts
                                   Study cohort
                                (number of analyzed   True     True                              McDonald’s
                                 paired serum and  positives  negatives    Cut-off Sensitivity Specificity diagnostic
                                   CSF samples)                                                    criteria
                Crespi et al. [54]  385        MS (127) Other neurological diseases:  ≥ 5  96  78  2017
                                                      IND (117)
                                                      NIND (141)
                Gaetani et al. [56]  170       RIS, CIS,  Other neurological diseases   ≥ 7.83  89  81  2010
                                               MS (64) (106):
                                                      IND (24)
                                                      NIND (82)
                Gurtner et al. [57]  320       RIS, CIS,  Other neurological diseases   ≥ 10.5  87  76  2010
                                               MS (67) (258):
                                                      autoimmune (53),
                                                      NIND (50),
                                                      IND (38),
                                                      degenerative (28), peripheral
                                                      neuropathy (24),
                                                      infection (13),
                                                      cancer (11),
                                                      neuromyelitis optica (10),
                                                      others (31)
                Leurs et al. [59]  745 (from 18   CIS, MS  Controls (219):   ≥ 6.6  88    83     2010 (84%)
                                   centers)    (526)  IND (67)                                   2005 (16%)
                                                      NIND (76)                   93 (MS   83 (MS
                                                      Symptomatic controls (49)   and     and
                                                      Healthy controls (27)       controls) controls)
                Pieri et al. [53]  176         MS (71)  Other neurological diseases:  ≥ 12.3  93  100  2010
                                                      IND (33)
                                                      NIND (72)
                Presslauer et al. [58]  438 (from 4   CIS/MS  Other neurological diseases   ≥ 5.9  96  86  2010
                                   centers)    (70)   (368), including meningitis/
                                                      encephalitis (41)
                                                      Guillain-Barré (15)
                                                      Neuroborreliosis (15)
                                                      CIDP (7)
                Puthenparampil et al. [55]  137  MS (70) Healthy controls (symtpomatic  ≥ 4.25  94  100  2017
                                                      despite no neurological and
                                                      systemic disorders) (37)
               MS: multiple sclerosis; CIS: clinically isolated syndrome; RIS: radiologically isolated syndrome; IND: inflammatory neurological diseases;
               NIND: non-inflammatory neurological diseases; CIDP: chronic inflammatory demyelinating polyneuropathy

               It has also been pointed out that higher values of KFLC index are associated with greater disability [60,64-66] ,
               even though previous authors did not go in the same direction but hypothesizing a prognostic role for this
               marker [61,67] .

               Measles-rubella-varicella-zoster reaction
               In the 1994 consensus report about CSF analysis in the diagnosis of MS, the detection of intrathecal Ig
               synthesis against neurotrophic viruses, such as measles, rubella and varicella-zoster, was considered a
                                                 [18]
               complementary diagnostic test for MS . Such kind of local humoral response, called measles-rubella-
               varicella-zoster (MRZ) reaction (MRZR), has been reported in up to 94% of patients with MS if at least one
                                                      [68]
               intrathecal virus-specific response is detected , with anti-measles response as the most frequent one [69-71] .
               However, MRZR is usually considered positive if a humoral response against at least 2 of 3 viruses is
               reported, with a commonly used cut-off value of 1.5 for antibody index [72,73] . The reason for this local
                                                                           [74]
                                                                                                       [75]
               humoral response, which occurs without active replication of the virus , has not been entirely clarified .
               An involvement of T lymphocytes promoting the differentiation of memory B cells into antibody secreting
                                    [70]
               ones has been suggested .
               High specificity of up to 97% for MRZR was also reported by Jarius and coworkers, who found a positive
               reaction in 78% of patients with MS compared to 3% of controls. Moreover, MRZR has proved to be able to
   20   21   22   23   24   25   26   27   28   29   30